/ /

  • linkedin
  • Increase Font
  • Sharebar

    What does 2017 have in store for ophthalmology?


    Where do you see the most growth in the field of ophthalmology?

    Dr. Masket: I believe that ocular imaging has shown and will continue to show the greatest expansion. In the foreseeable future I believe that OCT imaging may replace tractional slit lamp exam and ophthalmoscopy.

    Dr. Snyder: I believe that angle-based glaucoma surgery will be a high growth area for 2017.

    Dr. Fekrat: Gene therapy, visual cortical prosthesis Robotic Retinal Dissection Device (R2D2), preventing vitreous liquefaction.

    Dr. Maloney: I think we will see significant growth in intracorneal inlays as a treatment for presbyopia.

    Dr. Hoffman: I still feel that the refractive surgery market including LASIK and Refractive Lens Exchange (RLE) is being underpromoted. There is a huge potential market for RLE which, unfortunately, is currently dependent on our economy and patient’s ability to cover the costs of these procedures.

    Dr. Lee: Laser technology, stem cell, gene therapy, OCT angiography

    Dr. Olson: IRIS could be more important than cataract surgery as far as profitability but could really hammer a lot of the present technology. My prediction is it will be huge for ophthalmology.

    Dr. Kornmehl: Inlays for presbyopia will become increasingly popular. It will be important for surgeons to offer both the Raindrop and KAMRA Inlays since they are most effective in different patient populations.

    New Call-to-action


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available


    View Results